Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
This study has been completed.
Sponsor:
Genzyme
Collaborator:
Diacrin/Genzyme Corporation LLC
Information provided by:
Genzyme
ClinicalTrials.gov Identifier:
NCT00226460
First received: September 23, 2005
Last updated: June 18, 2008
Last verified: September 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | January 2001 |
| Estimated Primary Completion Date: | No date given |